Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 45, Issue 8, Page 1 (August 2010)


View previous. 2 of 21 View next.

Hormone Tx Risk:Benefit Ratio Favors Use in Newly Menopausal

DOUG BRUNK

SAN DIEGO — The scale that weighs risks and benefits tips more favorably for newly menopausal women who begin hormone therapy at age 50-59 years and who use it for 5 years, compared with women who start the therapy in their 60s, according to a systematic review of several studies and position statements.

 From the Annual Meeting of the Endocrine Society

PII: S0029-7437(10)70290-1

doi:10.1016/S0029-7437(10)70290-1


View previous. 2 of 21 View next.